Form 4: Invivyd Director Terrance McGuire Sells Shares in Multiple Transactions

Invivyd director Terrance McGuire sold a total of 190,359 shares of common stock in two separate transactions on December 12th and 16th, 2024.

Summary

• Terrance McGuire, a director at Invivyd, Inc., sold 125,000 shares of common stock on December 12, 2024, at a weighted average price of $0.583 per share.
• The shares were sold in multiple transactions with prices ranging from $0.5800 to $0.5978.
• On December 16, 2024, McGuire sold an additional 65,359 shares at a weighted average price of $0.4668 per share.
• These shares were also sold in multiple transactions with prices ranging from $0.4501 to $0.4959.
• Following these transactions, McGuire's indirectly held shares decreased to 4,012,320, with additional indirect holdings through various Polaris venture funds.
• McGuire disclaims beneficial ownership of these shares except to the extent of his pecuniary interest.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to the director selling shares, especially at a lower price on the second transaction. This could indicate a lack of confidence in the company's short-term prospects.

Negatives

• The director's sale of shares could be interpreted negatively by the market.

Risks

• The sales by a director may raise concerns about the company's future prospects.
• The weighted average sale price of $0.4668 on December 16th is significantly lower than the $0.583 on December 12th, which could indicate a negative trend.

Industry Context

This is a routine disclosure of stock sales by a company director, which is common in the biotech industry. Such transactions are closely watched by investors for insights into management's view of the company's prospects.

Comparison to Industry Standards

• Director share sales are a common occurrence in publicly traded companies, particularly in the biotech sector where stock options and equity compensation are prevalent.
• The volume of shares sold by Terrance McGuire is not unusual for a director, but the price fluctuations between the two sales dates may warrant further scrutiny.
• Comparable companies often see similar filings, and the market reaction is typically based on the overall context of the company's performance and outlook.

Stakeholder Impact

• Shareholders may react negatively to the director's share sales, potentially leading to a decrease in stock price.
• The sales could impact investor confidence in the company's future performance.

Key Dates

Keywords

Invivyd, Terrance McGuire, share sale, director, insider trading, Polaris Partners, common stock, SEC Form 4